The United States allows an anti -liff nodes

The health authorities in the United States have authorized a new cancer -invented medicine, as it aims to address a difficult form of lymphoma. The Swiss company said in a statement on Friday that this drug “Columvi” patients treated patients with the form of lymph nodes, known as the designation of the large bi -bi -cell mutuma. ‘Roche’ indicated that the US Food and Drug Administration ‘FDA’ K these bipolar -stimulating anti -cells authorized in adult patients, as the drug will be available within the next few weeks. Treatment is for patients who have already received two or more treatment for treatment for this type of leukemia, but they have been degenerated or not recovered after currently receiving affirmative treatments. In the event that a large number of patients are well available with the treatments in the first place, relax up to 40 % of them or resistance to treatments, and the options are limited, while their survival rate is small, according to “Roche”. This kind of cancer extends approximately 160,000 people around the world annually, according to “Roche”, which is the first in the world in the field of oncology. Also read: